1. Schwartz ID, Root AW. The Klinefelter syndrome of testicular dysgenesis. Endocrinol Metab Clin North Am. 1991. 20:153–163.
2. Bojesen A, Juul S, Gravholt CH. Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab. 2003. 88:622–626.
3. Ratcliffe S. Long-term outcome in children of sex chromosome abnormalities. Arch Dis Child. 1999. 80:192–195.
4. Moon HJ, Rhim CY, Kim GW, et al. Risk factors of deep vein thrombosis and pulmonary embolism in Korean. Korean Circ J. 2005. 35:474–479.
5. Campbell WA, Price WH. Venous thromboembolic disease in Klinefelter's syndrome. Clin Genet. 1981. 19:275–280.
6. Bennet A, Sie P, Caron P, et al. Plasma fibrinolytic activity in a group of hypogonadic men. Scand J Clin Lab Invest. 1987. 47:23–27.
7. Caron P, Bennet A, Camare R, Louvet JP, Boneu B, Sié P. Plasminogen activator inhibitor in plasma is related to testosterone in men. Metabolism. 1989. 38:1010–1015.
8. Winkler UH. Effects of androgens on haemostasis. Maturitas. 1996. 24:147–155.
9. Lane DA, Philippou H, Huntington JA. Directing thrombin. Blood. 2005. 106:2605–2612.
10. Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood. 1987. 69:381–387.
11. Lapecorella M, Marino R, De Pergola G, Scaraggi FA, Speciale V, De Mitrio V. Severe venous thromboembolism in a young man with Klinefelter's syndrome and heterozygosis for both G20210A prothrombin and factor V Leiden mutations. Blood Coagul Fibrinolysis. 2003. 14:95–98.